Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06415760 · ClinicalTrials.gov registry record

Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients

A clinical trial, sponsored by HemoSonics.

Completed
Registry status
129
Enrollment target

NCT06415760 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 129 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06415760 has completed, sponsored by HemoSonics.

COMPLETED
Registry status
129 participants
Enrollment target

Study Summary

This study will determine reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge in the last trimester of non-laboring pregnant women with an uncomplicated pregnancy

Interventions

  • DIAGNOSTIC_TEST Quantra System

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2024-05-07
Est. Completion 2025-07-01

Sponsor

HemoSonics

24 total trials

What the Registry Record Tells You About NCT06415760

The ClinicalTrials.gov registry entry for NCT06415760 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.

NCT06415760 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06415760 about?

NCT06415760 is a clinical study titled "Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients". This study will determine reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge in the last trimester of non-laboring pregnant women with an uncomplicated pregnancy

What is the current status of trial NCT06415760?

This trial is currently completed. The enrollment target is 129 participants. The study started on 2024-05-07. Estimated completion is 2025-07-01.

What interventions are being tested in trial NCT06415760?

The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06415760?

This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.